Acute renal infarction in a patient with COVID-19 receiving warfarin therapy

Abstract

Abstract Acute renal infarction is a rare clinical condition that usually occurs as a result of atherosclerosis, autoimmune diseases, hypercogulability, atrial fibrillation and infectious diseases. In herein, we aimed to present a case of renal infarction in a 63-year-old male patient who was hospitalized due to COVID-19 infection, receiving warfarin therapy and had a high international normalized ratio (INR) value. Özet Akut renal infarkt genellikle ateroskleroz, otoimmun hastalıklar, hiperkoagulabilite, atriyal fibrilasyon ve enfeksiyon hastalıkları sonucu ortaya çıkan nadir görülen klinik bir durumdur. Burada, COVID-19 nedeniyle hastanede yatan, warfarin tedavisi alan ve yüksek INR değerine sahip 63 yaşındaki erkek bir renal infarkt olgusunu sunmayı amaçladık.

Keywords

• renal infarction
• COVID-19
• warfarin

References

1. 1. Yang, J., Lee, J.Y., Na, J.Y., Lim, S.Y., Kim, M.G., Jo, S.K., et al. (2016). Risk factors and outcomes of acute renal infarction. Kidney Res Clin Pract, 35(2): 90–95.
2. 2. Covarrubias, N.B., Toledo, M.P., Thomas, M.R., Henderson, I.R., Watson, S.P., Cunningham, A.F. (2019). Understanding infection-induced thrombosis: lessons learned from animal models. Front Immunol, 10: 2569.
3. 3. Tang, N., Li, D., Wang, X., Sun, Z. (2020) Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost, 18:844–847.
4. 4. Eltawansy, S.A., Patel, S., Rao, M., Hassanien, S., Maniar, M. (2014). Acute renal infarction presenting with acute abdominal pain secondary to newly discovered atrial fibrillation: a case report and literature review. Case Rep Emerg Med, 981409.
5. 5. Geisbert, T.W., Young, H.A., Jahrling, P.B., Davis, K.J., Kagan, E., Hensley, L.E. (2003). Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event. J Infect Dis, 188:1618–29.
6. 6. Short, K.R., Kroeze, E., Fouchier, R.A.M., Kuiken, T. (2014). Pathogenesis of influenza induced acute respiratory distress syndrome. Lancet Infect Dis, 14:57–69.
7. 7. Connors, J.M., Levy, J.H. (2020). COVID-19 and its implications for thrombosis and anticoagulation. Blood, 135 (23): 2033–40.
8. 8. Becker, R.C. (2020). COVID-19 update: Covid-19-associated coagulopathy. J Thromb Thrombolysis, 15: 1–14.